Brentuximab vedotin.
Anas
A
Younes
Uma
U
Yasothan
Peter
P
Kirkpatrick
D000818:Animals; D000079963:Brentuximab Vedotin; D017321:Clinical Trials, Phase I as Topic / Q000639:trends; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D018796:Immunoconjugates / Q000627:therapeutic use*; D017730:Ki-1 Antigen / Q000276:immunology*; D017728:Lymphoma, Large-Cell, Anaplastic / Q000188:drug therapy
D018796:Immunoconjugates; D017730:Ki-1 Antigen; D000079963:Brentuximab Vedotin